account_balance
Investment manager · 13F filer · SEC CIK 2054410
Acorn Capital Advisors, LLC
Reported value$366Mas of Jun 30, 2026
Positions20 1 new, 3 sold out
Top 10 weight90.2%CGON alone is 22%
FiledAug 1445 days after quarter end
Portfolio · as of Jun 30, 2026
Where the money is
New or addedTrimmedHeld
CGONCg Oncology Inc
21.9%
URGNUrogen Pharma Ltd
16.8%
TRVITrevi Therapeutics Inc
10.9%
CADLCandel Therapeutics Inc
9.8%
PBYIPuma Biotechnology Inc
9.1%
JBIOJade Biosceinces Inc
6.0%Added +25%
BCAXBicara Therapeutics
5.2%
KPTIKaryopharm Therapeutics Inc
4.0%Added +427%
OKUROnkure Therapeutics Inc
3.5%
HELPHelus Pharma Inc.
2.8%
TARA1.8%AURA1.8%CGONCg Oncology Inc
21.9%
URGNUrogen Pharma Ltd
16.8%
TRVITrevi Therapeutics Inc
10.9%
CADLCandel Therapeutics Inc
9.8%
PBYIPuma Biotechnology Inc
9.1%
JBIO6.0%BCAX5.2%KPTI4.0%OKUR3.5%HELPTARA1.8%AURABoxes show the top 12 stocks, sized against each other. The bar above shows how much of the fund they are. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
Show the top 12 as a list
CGON Cg Oncology Inc 21.9% HeldURGN Urogen Pharma Ltd 16.8% HeldTRVI Trevi Therapeutics Inc 10.9% HeldCADL Candel Therapeutics Inc 9.8% HeldPBYI Puma Biotechnology Inc 9.1% HeldJBIO Jade Biosceinces Inc 6.0% Added +25%BCAX Bicara Therapeutics 5.2% HeldKPTI Karyopharm Therapeutics Inc 4.0% Added +427%OKUR Onkure Therapeutics Inc 3.5% HeldHELP Helus Pharma Inc. 2.8% HeldTARA Protara Therapeutics Inc 1.8% HeldAURA Aura Biosciences Inc 1.8% Added +56%
What changed